Evidence map›Paper›PMID 17362200›Full record

ReviewAnnual review of biochemistry2007

Lipid A modification systems in gram-negative bacteria.

Christian R H Raetz, C Michael Reynolds, M Stephen Trent, Russell E Bishop

Abstract readReview
In one paragraph

Review in Annual review of biochemistry, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 735 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
735citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

735 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  8. Review
  9. Article
  10. Adaptive Response ofAntibiotics (Basel, Switzerland) · 2026
    Article
  11. Identification ofAntibiotics (Basel, Switzerland) · 2026
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Journal of bacteriology · 2026
    Article

675 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Christian R H RaetzDepartment of Biochemistry, Duke University Medical Center, Durham, North Carolina 27710, USA. raetz@biochem.duke.edu
C Michael Reynolds
M Stephen Trent
Russell E Bishop

Funding

BIOSYNTHESIS AND FUNCTION OF LIPOPOLYSACCHARIDESR01GM051310 · NIGMS · DUKE UNIVERSITY · PI ZHOU, PEI · 1994 to 2013
$8.1M
MODIFICATION OF HELICOBACTER PYLORI LIPOPOLYSACCHARIDESR01AI064184 · NIAID · UNIVERSITY OF TEXAS AT AUSTIN · PI TRENT, MICHAEL STEPHEN · 2006 to 2015
$3.4M
LIPID A MODIFICATION SYSTEMS IN GRAM-NEGATIVE BACTERIAR37GM051796 · NIGMS · DUKE UNIVERSITY · PI RAETZ, CHRISTIAN R · 1999 to 2008
$3.0M
Lipid A Modification Systems in Gram-Negative BacteriaR01GM051796 · NIGMS · DUKE UNIVERSITY · PI ZHOU, PEI · 1995 to 2012
$1.5M
NIAID NIH HHS AI-064184NIAID NIH HHS R01 AI064184NIGMS NIH HHS GM-51310NIGMS NIH HHS GM-51796NIGMS NIH HHS R01 GM051310NIGMS NIH HHS R01 GM051796NIGMS NIH HHS R37 GM051796
6 · The paper itself

Abstract

The lipid A moiety of lipopolysaccharide forms the outer monolayer of the outer membrane of most gram-negative bacteria. Escherichia coli lipid A is synthesized on the cytoplasmic surface of the inner membrane by a conserved pathway of nine constitutive enzymes. Following attachment of the core oligosaccharide, nascent core-lipid A is flipped to the outer surface of the inner membrane by the ABC transporter MsbA, where the O-antigen polymer is attached. Diverse covalent modifications of the lipid A moiety may occur during its transit from the outer surface of the inner membrane to the outer membrane. Lipid A modification enzymes are reporters for lipopolysaccharide trafficking within the bacterial envelope. Modification systems are variable and often regulated by environmental conditions. Although not required for growth, the modification enzymes modulate virulence of some gram-negative pathogens. Heterologous expression of lipid A modification enzymes may enable the development of new vaccines.

Indexed as

Carbohydrate ConformationCarbohydrate SequenceCell MembraneFatty AcidsGram-Negative BacteriaLipid ALipopolysaccharidesModels, MolecularMolecular Sequence DataMolecular StructureProtein Structure, TertiaryUridine Diphosphate N-AcetylglucosamineFatty AcidsKdo2-lipid ALipid ALipopolysaccharidesUridine Diphosphate N-Acetylglucosamine

Identifiers

PMID17362200
PMCPMC2569861

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.